BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chisholm JA, Mayne GC, Hussey DJ, Watson DI. Molecular biomarkers and ablative therapies for Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2012;6:567-81. [PMID: 23061708 DOI: 10.1586/egh.12.39] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Sreedharan L, Mayne GC, Watson DI, Bright T, Lord RV, Ansar A, Wang T, Kist J, Astill DS, Hussey DJ. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett’s esophagus. World J Gastroenterol 2017; 23(30): 5508-5518 [PMID: 28852310 DOI: 10.3748/wjg.v23.i30.5508] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
2 Blum A, Chak A. FISH then grill? Using biomarkers to predict response to ablation. Gastrointest Endosc 2014;80:992-4. [PMID: 25434657 DOI: 10.1016/j.gie.2014.07.051] [Reference Citation Analysis]
3 Levert-Mignon A, Bourke MJ, Lord SJ, Taylor AC, Wettstein AR, Edwards M, Botelho NK, Sonson R, Jayasekera C, Fisher OM, Thomas ML, Macrae F, Hussey DJ, Watson DI, Lord RV. Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma. United European Gastroenterol J 2017;5:13-20. [PMID: 28405317 DOI: 10.1177/2050640616650794] [Reference Citation Analysis]